RT Journal Article
SR Electronic
T1 RSV immunization in adults and children: A practical guide for clinicians
JF Cleveland Clinic Journal of Medicine
JO Cleve Clin J Med
FD Cleveland Clinic
SP S11
OP S18
DO 10.3949/ccjm.91.s1.03
VO 91
IS 9 suppl 1
A1 DeVolld, Trate
A1 Rivard, Kaitlyn R.
YR 2024
UL http://www.ccjm.org/content/91/9_suppl_1/S11.abstract
AB In 2023 and 2024, 3 vaccines were approved by the US Food and Drug Administration (FDA) against respiratory syncytial virus (RSV) in adults. In addition, the first long-acting RSV monoclonal antibody for infants and young children was approved. This review provides clinicians with practical guidance to navigate this new era of RSV prevention.